FUNI - Comprehensive Filing Intelligence

Q1•10-Q•Filed Feb 17, 2026

3.0/10

Filing Health:CONCERN

Significant issues identified across multiple dimensions

Executive Summary

The company has shifted its business focus from cannabis testing to developing a bioreactor for mushroom production, with significant investment in the new venture.. The company has a significant operating lease liability with a total undiscounted future payment of $17,275, which expires in 2026.. Sale of Digipath Labs assets on February 20, 2024.

Top Concerns

!The company is burning through cash from operations and faces substantial doubt about its ability to continue as a going concern, seeking additional financing.
!The company has a significant operating lease liability with a total undiscounted future payment of $17,275, which expires in 2026.
!Related party transactions include compensation and stock grants to the sole officer, with a note that these may not be arm's length.
!Going Concern Uncertainty and Capital Structure (high)
!Material Weaknesses in Internal Controls (high)

Top Positives

+Operating expenses decreased significantly due to a one-time stock-based compensation event in the prior year, masking the true operational cost increase.
+Professional fees and interest expenses have increased, reflecting ongoing development costs and increased debt financing for the new business.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

3.0/10

Management tone is balanced.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

5.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low with $17,275 in identified exposure.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

2.0/10

Overall risk profile shows going concern uncertainty and capital structure as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

1.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.